Changes in Tumor Necrosis Factor Inhibitor Drug Survival in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Over 15 Years.

MLA

Visman, Ingrid M., et al. “Changes in Tumor Necrosis Factor Inhibitor Drug Survival in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Over 15 Years.” Journal of Rheumatology, vol. 51, no. 1, Jan. 2024, pp. 84–87. EBSCOhost, https://doi.org/10.3899/jrheum.2023-0149.

APA

Visman, I. M., Atiqi, S., Boers, M., Twisk, J. W. R., & Nurmohamed, M. T. (2024). Changes in Tumor Necrosis Factor Inhibitor Drug Survival in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Over 15 Years. Journal of Rheumatology, 51(1), 84–87. https://doi.org/10.3899/jrheum.2023-0149

Chicago

Visman, Ingrid M., Sadaf Atiqi, Maarten Boers, Jos W. R. Twisk, and Michael T. Nurmohamed. 2024. “Changes in Tumor Necrosis Factor Inhibitor Drug Survival in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Over 15 Years.” Journal of Rheumatology 51 (1): 84–87. doi:10.3899/jrheum.2023-0149.